D68 Other coagulation defects
D68 is the ICD-10-CM code family for Other coagulation defects: 25 codes, all of which can lead a home health claim.
Codes in family
25
Can lead a claim
25
Cannot lead a claim
0
What CMS assigns to D68
All 25 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. 19 of the 25 count toward the Coagulation Defects and Cytokine Release Syndromes comorbidity subgroup; 6 are assigned none. Every code can lead a claim.
- Coagulation Defects and Cytokine Release Syndromes
Every code in D68
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| D68.0 Von Willebrand disease | ||||
| D68.00 | Von Willebrand disease, unspecified | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.01 | Von Willebrand disease, type 1 | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.02 Von Willebrand disease, type 2 | ||||
| D68.020 | Von Willebrand disease, type 2A | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.021 | Von Willebrand disease, type 2B | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.022 | Von Willebrand disease, type 2M | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.023 | Von Willebrand disease, type 2N | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.029 | Von Willebrand disease, type 2, unspecified | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.03 | Von Willebrand disease, type 3 | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.04 | Acquired von Willebrand disease | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.09 | Other von Willebrand disease | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.1 | Hereditary factor XI deficiency | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.2 | Hereditary deficiency of other clotting factors | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.3 Hemorrhagic disorder due to circulating anticoagulants | ||||
| D68.31 Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors | ||||
| D68.311 | Acquired hemophilia | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.312 | Antiphospholipid antibody with hemorrhagic disorder | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.318 | Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitorsCMS: Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.32 | Hemorrhagic disorder due to extrinsic circulating anticoagulantsCMS: Hemorrhagic disord d/t extrinsic circulating anticoagulants | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.4 | Acquired coagulation factor deficiency | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.5 Primary thrombophilia | ||||
| D68.51 | Activated protein C resistance | Can lead a claim | K | None |
| D68.52 | Prothrombin gene mutation | Can lead a claim | K | None |
| D68.59 | Other primary thrombophilia | Can lead a claim | K | None |
| D68.6 Other thrombophilia | ||||
| D68.61 | Antiphospholipid syndrome | Can lead a claim | K | None |
| D68.62 | Lupus anticoagulant syndrome | Can lead a claim | K | None |
| D68.69 | Other thrombophilia | Can lead a claim | K | None |
| D68.8 | Other specified coagulation defects | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
| D68.9 | Coagulation defect, unspecified | Can lead a claim | K | Coagulation Defects and Cytokine Release Syndromes |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.